KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) EBITDA: 2020-2025

Historic EBITDA for Hims & Hers Health (HIMS) over the last 6 years, with Sep 2025 value amounting to $15.9 million.

  • Hims & Hers Health's EBITDA fell 79.11% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.5 million, marking a year-over-year increase of 32.34%. This contributed to the annual value of $125.8 million for FY2024, which is 637.93% up from last year.
  • Hims & Hers Health's EBITDA amounted to $15.9 million in Q3 2025, which was down 63.50% from $43.5 million recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's EBITDA ranged from a high of $76.0 million in Q3 2024 and a low of -$51.5 million during Q1 2021.
  • Its 3-year average for EBITDA is $19.2 million, with a median of $13.3 million in 2024.
  • As far as peak fluctuations go, Hims & Hers Health's EBITDA tumbled by 853.08% in 2021, and later skyrocketed by 1,931.26% in 2024.
  • Quarterly analysis of 5 years shows Hims & Hers Health's EBITDA stood at -$31.2 million in 2021, then spiked by 65.69% to -$10.7 million in 2022, then surged by 111.70% to $1.3 million in 2023, then surged by 1,931.26% to $25.5 million in 2024, then crashed by 79.11% to $15.9 million in 2025.
  • Its last three reported values are $15.9 million in Q3 2025, $43.5 million for Q2 2025, and $49.6 million during Q1 2025.